Article Text

Original article
Alternative splicing modifies the effect of mutations in COL11A1 and results in recessive type 2 Stickler syndrome with profound hearing loss
  1. Allan J Richards1,2,
  2. Gregory S Fincham3,
  3. Annie McNinch1,2,3,
  4. David Hill2,
  5. Arabella V Poulson3,
  6. Bruce Castle4,
  7. Melissa M Lees5,
  8. Anthony T Moore6,
  9. John D Scott3,
  10. Martin P Snead3
  1. 1Department of Pathology, University of Cambridge, Cambridge, UK
  2. 2Regional Molecular Genetics Laboratory, Addenbrooke's Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK
  3. 3Vitreoretinal Service, Addenbrooke's Hospital, Cambridge University NHS Foundation Trust, Cambridge, UK
  4. 4Peninsular Clinical Genetics Department, Royal Devon & Exeter NHS Foundation Trust, Exeter, UK
  5. 5Department of Clinical Genetics, North East Thames Regional Genetics Service, Great Ormond Street Hospital, London, UK
  6. 6University College London, Institute of Ophthalmology, London, UK
  1. Correspondence to Dr Martin Snead, Vitreoretinal Service, Addenbrooke's Hospital, Cambridge University NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK; mps34{at}cam.ac.uk

Abstract

Background Stickler syndromes types 1, 2 and 3 are usually dominant disorders caused by mutations in the genes COL2A1, COL11A1 and COL11A2 that encode the fibrillar collagens types II and XI present in cartilage and vitreous. Rare recessive forms of Stickler syndrome exist that are due to mutations in genes encoding type IX collagen (COL9A1 type 4 Stickler syndrome and COL9A2 type 5 Stickler syndrome). Recently, recessive mutations in the COL11A1 gene have been demonstrated to result in fibrochondrogenesis, a much more severe skeletal dysplasia, which is often lethal. Here we demonstrate that some mutations in COL11A1 are recessive, modified by alternative splicing and result in type 2 Stickler syndrome rather than fibrochondrogenesis.

Methods Patients referred to the national Stickler syndrome diagnostic service for England, UK were assessed clinically and subsequently sequenced for mutations in COL11A1. Additional in silico and functional studies to assess the effect of sequence variants on pre-mRNA processing and collagen structure were performed.

Results In three different families, heterozygous COL11A1 biallelic null, null/missense or silent/missense mutations, were found. They resulted in a recessive form of type 2 Stickler syndrome characterised by particularly profound hearing loss and are clinically distinct from the recessive types 4 and 5 variants of Stickler syndrome. One mutant allele in each family is capable of synthesising a normal α1(XI) procollagen molecule, via variable pre-mRNA processing.

Conclusion This new variant has important implications for molecular diagnosis and counselling families with type 2 Stickler syndrome.

  • Stickler syndrome
  • Recessive Inheritance
  • Alternative Splicing

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Supplementary materials

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement: